AMP-activated protein kinase and type 2 diabetes

Current Medicinal Chemistry
Nicolas Musi

Abstract

AMP-activated protein kinase (AMPK) is an enzyme that works as a fuel gauge, being activated in situations of high-energy phosphate depletion. Upon activation, AMPK functions to restore cellular ATP by modifying diverse metabolic pathways. AMPK is activated robustly by skeletal muscle contraction and myocardial ischemia, and may be involved in the stimulation of glucose transport and fatty acid oxidation produced by these stimuli. In liver, activation of AMPK results in enhanced fatty acid oxidation and in decreased production of glucose, cholesterol, and triglycerides. Recent studies have shown that AMPK is the cellular mediator for many of the metabolic effects of drugs such as metformin and thiazolidinediones, as well as the insulin sensitizing adipocytokines leptin and adiponectin. These data, along with evidence from studies showing that chemical activation of AMPK in vivo with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) improves blood glucose concentrations and lipid profiles, make this enzyme an attractive pharmacological target for the treatment of type 2 diabetes and other metabolic disorders.

Citations

Nov 10, 2010·The Journal of Biological Chemistry·Jiangyong OuyangRaymond S Ochs
Feb 4, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Dene R LittlerSirano Dhe-Paganon
Mar 25, 2011·Future Medicinal Chemistry·Eijiro YamadaClaire C Bastie
Sep 27, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Jing YangXinzhou Yang
Aug 9, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Stefano D'ErricoGennaro Piccialli
Feb 20, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Mei-Hsing ChenChun-Ching Shih
Apr 2, 2016·Experimental & Molecular Medicine·Joungmok KimJoohun Ha
Feb 2, 2010·Biological & Pharmaceutical Bulletin·Sung Jip KimSung Hyun Chung
Jan 27, 2007·The Journal of Biological Chemistry·Yong WuMing-Hui Zou
Apr 11, 2009·Journal of Applied Physiology·Robert S Lee-YoungGlenn K McConell
Apr 26, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yu-Te YehShu-Chen Hsieh
Feb 13, 2018·Experimental and Therapeutic Medicine·Ri-Su NaZhi-Wen Liu
Sep 1, 2006·The Journal of Biological Chemistry·Marianne SuterDietbert Neumann
Nov 10, 2011·American Journal of Physiology. Endocrinology and Metabolism·Ying ZhangJianfa Zhang
Sep 29, 2019·Biomolecules·Shima TavakolAlan Prem Kumar
Sep 19, 2019·JCI Insight·Yazmin I Rovira GonzalezKathryn R Wagner
May 31, 2013·The Journal of Biological Chemistry·Veeravenkata S Vytla, Raymond S Ochs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.